Indian carmaker Mahindra & Mahindra Ltd. announced its willingness to lower its shareholdings to below 50 percent and give up its controlling status at SsangYong Motor Co. if it finds a new investor.
Mahindra has a 74.65 percent stake in SsangYong Motor.
Mahindra Managing Director Pawan Goenka also revealed that talks with potential investors are underway.
According to Goenka, Mahindra is having difficulty finding a new investor in SsangYong while keeping the majority stake.
The car company also emphasized that it does not plan to inject fresh capital into SsangYong.
In April, Mahindra's board had rejected an earlier plan to inject 230 billion won US$194 million into SsangYong for the next three years.
Instead, Mahindra would consider a one-time infusion of up to 40 billion in three months to SsangYong to help shoulder operations.
SsangYong Motor has reported net losses in the past 14 quarters through the second quarter of this year.
From January to July, SsangYong sold 56,846 vehicles, down 28 percent from 78,687 units in the same period last year.
Its lineup consists of the flagship G4 Rexton, Rexton Sports, Tivoli, and Korando sport utility vehicles.


xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
U.S. Stock Futures Rise as Trump Takes Office, Corporate Earnings Awaited
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
Mexico's Undervalued Equity Market Offers Long-Term Investment Potential
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement
Wall Street Rebounds as Investors Eye Tariff Uncertainty, Jobs Report
Insignia Financial Shares Hit 3-Year High Amid Bain and CC Capital Bidding War
Investors value green labels — but not always for the right reasons
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10%
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales
Investors Brace for Market Moves as Trump Begins Second Term
Infosys Shares Drop Amid Earnings Quality Concerns
Elliott Investment Management Takes Significant Stake in BP to Push for Value Growth 



